For HNSC, the important candidates are mainly enriched in pathways in cancer, prostate cancer, glioma, non-small cell lung cancer, melanoma, ErbB signaling pathway and so on after KEGG pathway enrichment (see Additional file 4). Here, EGFR is linked to prostate carcinoma.